Corcept Therapeutics Incorporated trailing returns
Corcept Therapeutics Incorporated's 10-year return is +33.2% a year (CAGR) (+1654.2% cumulative). How Corcept Therapeutics Incorporated (CORT) has performed over the last day, week, month and year, over 5, 10 and 20 years, and since inception, through October 1, 2026 — cumulative and annualized, with dividends on or off.
Trailing returns by period#
To 2026-10-01. Annualized (CAGR) for windows of a year or more.
| Period | Path | Annualized | Cumulative |
|---|---|---|---|
| 1 day | — | -1.0% | |
| 5 days | — | -3.8% | |
| 1 month | — | +0.6% | |
| YTD | — | +227.7% | |
| 1 year | +35.3% | +35.3% | |
| 5 years | +41.9% | +474.7% | |
| 10 years | +33.2% | +1654.2% | |
| 20 years | +27.2% | +12160.8% | |
| Since inception (2004) | +10.4% | +832.3% |
Growth of CORT
Actual index level (solid); dashed lines are each window's constant-rate path from start to today.
Methodology#
Trailing returns measure from the closest close about N years before the latest close (2026-10-01). Cumulative return is the total change over the window; annualized return is the compound annual growth rate (CAGR), shown for windows of a year or more. Total return reinvests dividends (from CORT's split- and dividend-adjusted closes); price return excludes them. See the year-by-year returns for the calendar breakdown. Past performance does not predict future returns; not investment advice.
FAQ#
- What is Corcept Therapeutics Incorporated's 10-year return?
- Over the last 10 years, Corcept Therapeutics Incorporated (CORT) returned about +33.2% a year annualized (+1654.2% cumulative total return).
- What is Corcept Therapeutics Incorporated's 20-year annualized return?
- Over the last 20 years, Corcept Therapeutics Incorporated (CORT) compounded at about +27.2% a year (+12160.8% cumulative).
- What is Corcept Therapeutics Incorporated's return since inception?
- Since 2004, Corcept Therapeutics Incorporated (CORT) has compounded at about +10.4% a year — +832.3% in total.